COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
Luxshare Precision Achieves a Two-Notch Upgrade to MSCI ESG Rating A, Demonstrating Continuous Strength in Sustainable Development
Luxshare Precision achieves a two-notch upgrade to MSCI ESG rating A, showcasing strong sustainability progress and ESG practices in clean tech, labor management, controversial sourcing, chemical safety, and governance -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Medicus Pharma Ltd. announces financial results and advancements in clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist. Company highlights important corporate updates and collaborations -
